Barinthus Biotherapeutics BRNS
BRNS
$0.74 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Barinthus Biotherapeutics (BRNS) Return on Assets [ROA] (2021 - 2026)

Updated

Barinthus Biotherapeutics' Return on Assets [ROA] was -48.04% in Q2 2026, up 3.15 percentage points from -51.19% a year earlier and up 6.95 percentage points from the prior quarter.

Analysis

Barinthus Biotherapeutics (BRNS) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Barinthus Biotherapeutics came in at -51.42%, down 18.77 percentage points from FY2024.

  • Return on Assets [ROA] has now declined for three consecutive years, with a four-year change of -20.57 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Assets [ROA] was -32.65% in FY2024 (-2.34 pp), -30.31% in FY2023 (-32.24 pp), 1.93% in FY2022 (+32.78 pp) and -30.85% in FY2021.
  • The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] since Q1 2025.
  • Compared with a year earlier, Return on Assets [ROA] was higher in two of the last eight quarters, with an average year-over-year change of -12.25 percentage points.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q3 2022 (a gain of 22.03 percentage points); the worst was Q3 2023 (a drop of 36.52 percentage points).
  • Per Business Quant data, BRNS's Return on Assets [ROA] in the three quarters before Q2 2026 was -55.00% (Q1 2026), -64.10% (Q4 2025) and -63.62% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Barinthus Biotherapeutics 30.23 Mn 30.29 Mn - -48.04%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -48.04%
Mar 31, 2026 -55.00%
Dec 31, 2025 -64.10%
Sep 30, 2025 -63.62%
Jun 30, 2025 -51.19%
Mar 31, 2025 -43.21%
Dec 31, 2024 -35.06%
Sep 30, 2024 -30.83%
Jun 30, 2024 -33.07%
Mar 31, 2024 -34.18%
Dec 31, 2023 -33.05%
Sep 30, 2023 -32.48%
Jun 30, 2023 -21.65%
Mar 31, 2023 -5.82%
Dec 31, 2022 1.95%
Sep 30, 2022 4.04%
Jun 30, 2022 -0.52%
Mar 31, 2022 -11.70%
Dec 31, 2021 -19.03%
Sep 30, 2021 -18.00%
API Access

Barinthus Biotherapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BRNS&period=max&api_key=YOUR_API_KEY